IL299769A - Eye supplement containing glucocorticoid - Google Patents
Eye supplement containing glucocorticoidInfo
- Publication number
- IL299769A IL299769A IL299769A IL29976923A IL299769A IL 299769 A IL299769 A IL 299769A IL 299769 A IL299769 A IL 299769A IL 29976923 A IL29976923 A IL 29976923A IL 299769 A IL299769 A IL 299769A
- Authority
- IL
- Israel
- Prior art keywords
- insert
- sustained release
- release biodegradable
- biodegradable ocular
- hydrogel
- Prior art date
Links
- 239000003862 glucocorticoid Substances 0.000 title claims 16
- 238000013268 sustained release Methods 0.000 claims 41
- 239000012730 sustained-release form Substances 0.000 claims 41
- 239000000017 hydrogel Substances 0.000 claims 22
- 239000002202 Polyethylene glycol Substances 0.000 claims 15
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 15
- 229960003957 dexamethasone Drugs 0.000 claims 15
- 229920001223 polyethylene glycol Polymers 0.000 claims 15
- 239000002245 particle Substances 0.000 claims 9
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 6
- 229920000642 polymer Polymers 0.000 claims 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims 4
- 239000002953 phosphate buffered saline Substances 0.000 claims 4
- 238000001035 drying Methods 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000003431 cross linking reagent Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000001667 episodic effect Effects 0.000 claims 2
- 238000003780 insertion Methods 0.000 claims 2
- 230000037431 insertion Effects 0.000 claims 2
- 239000002243 precursor Substances 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 230000000717 retained effect Effects 0.000 claims 2
- 238000007493 shaping process Methods 0.000 claims 2
- 238000012800 visualization Methods 0.000 claims 2
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 1
- 102000051628 Interleukin-1 receptor antagonist Human genes 0.000 claims 1
- 108700021006 Interleukin-1 receptor antagonist Proteins 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 229920001400 block copolymer Polymers 0.000 claims 1
- 239000008366 buffered solution Substances 0.000 claims 1
- 238000005266 casting Methods 0.000 claims 1
- 230000001268 conjugating effect Effects 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 125000004185 ester group Chemical group 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 230000036571 hydration Effects 0.000 claims 1
- 238000006703 hydration reaction Methods 0.000 claims 1
- 229940054136 kineret Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000269 nucleophilic effect Effects 0.000 claims 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims 1
- 229920001308 poly(aminoacid) Polymers 0.000 claims 1
- 229920000747 poly(lactic acid) Polymers 0.000 claims 1
- 229920001515 polyalkylene glycol Polymers 0.000 claims 1
- 239000004626 polylactic acid Substances 0.000 claims 1
- 229920001451 polypropylene glycol Polymers 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 229920005604 random copolymer Polymers 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063052646P | 2020-07-16 | 2020-07-16 | |
| US202063124176P | 2020-12-11 | 2020-12-11 | |
| US202163181720P | 2021-04-29 | 2021-04-29 | |
| PCT/US2021/041761 WO2022015940A1 (en) | 2020-07-16 | 2021-07-15 | Ocular insert containing a glucocorticoid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL299769A true IL299769A (en) | 2023-03-01 |
Family
ID=77300995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL299769A IL299769A (en) | 2020-07-16 | 2021-07-15 | Eye supplement containing glucocorticoid |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4181930A1 (zh) |
| JP (1) | JP2023534952A (zh) |
| KR (1) | KR20230041708A (zh) |
| CN (1) | CN116133664A (zh) |
| AU (1) | AU2021309965A1 (zh) |
| BR (1) | BR112023000669A2 (zh) |
| CA (1) | CA3174217A1 (zh) |
| IL (1) | IL299769A (zh) |
| MX (1) | MX2023000628A (zh) |
| WO (1) | WO2022015940A1 (zh) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008044935A (ja) | 2006-07-20 | 2008-02-28 | Sicor Inc | 固体状無菌活性医薬成分を製造する方法 |
| EP2156823A1 (en) | 2008-08-14 | 2010-02-24 | Pharmatex Italia Srl | Process for the preparation of sterile powdered pharmeceutical compounds in the form of micro and nanoparticles |
| US8409606B2 (en) * | 2009-02-12 | 2013-04-02 | Incept, Llc | Drug delivery through hydrogel plugs |
| US11369591B2 (en) | 2015-05-12 | 2022-06-28 | Incept, Llc | Drug delivery from hydrogels |
| CA3038075A1 (en) * | 2016-09-23 | 2018-03-29 | Incept, Llc | Intracameral drug delivery depots |
-
2021
- 2021-07-15 AU AU2021309965A patent/AU2021309965A1/en active Pending
- 2021-07-15 WO PCT/US2021/041761 patent/WO2022015940A1/en unknown
- 2021-07-15 IL IL299769A patent/IL299769A/en unknown
- 2021-07-15 JP JP2023502835A patent/JP2023534952A/ja active Pending
- 2021-07-15 CN CN202180060084.6A patent/CN116133664A/zh active Pending
- 2021-07-15 KR KR1020237002637A patent/KR20230041708A/ko unknown
- 2021-07-15 BR BR112023000669A patent/BR112023000669A2/pt unknown
- 2021-07-15 CA CA3174217A patent/CA3174217A1/en active Pending
- 2021-07-15 EP EP21752805.8A patent/EP4181930A1/en active Pending
- 2021-07-15 MX MX2023000628A patent/MX2023000628A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021309965A1 (en) | 2023-02-23 |
| JP2023534952A (ja) | 2023-08-15 |
| MX2023000628A (es) | 2023-02-27 |
| BR112023000669A2 (pt) | 2023-04-25 |
| CA3174217A1 (en) | 2022-01-20 |
| KR20230041708A (ko) | 2023-03-24 |
| CN116133664A (zh) | 2023-05-16 |
| EP4181930A1 (en) | 2023-05-24 |
| WO2022015940A1 (en) | 2022-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6770157B2 (ja) | 特定の投薬量の活性物質を皮膚又は粘膜に投与するための電気流体力学的に得られた繊維を含む組成物 | |
| US5714159A (en) | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof | |
| US6413539B1 (en) | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof | |
| Kasza et al. | Challenges and solutions in polymer drug delivery for bacterial biofilm treatment: a tissue-by-tissue account | |
| KR20010102088A (ko) | 질에 투여되는 연장방출 생물접착성 겔약형 | |
| Freag et al. | Exploiting polymer blending approach for fabrication of buccal chitosan-based composite sponges with augmented mucoadhesive characteristics | |
| RU2009117882A (ru) | ГИДРОГЕЛЕВАЯ РАНЕВАЯ ПОВЯЗКА И БИОМАТЕРИАЛЫ, СФОРМИРОВАННЫЕ in situ, И ИХ ПРИМЕНЕНИЕ | |
| Asati et al. | Bioadhesive or mucoadhesive drug delivery system: a potential alternative to conventional therapy | |
| EP0481600A2 (en) | Materials useful in human and veterinary medicine | |
| KR20220084381A (ko) | 생분해성 중합체를 갖는 용해성 중합체 눈 삽입물 | |
| JP2020022787A (ja) | 適用部位における滞留時間が改善された、電気流体力学的に得られた繊維を含む医薬組成物 | |
| HRP20230800T1 (hr) | Očni usadak koji sadrži inhibitor tirozin kinaze | |
| Habibi et al. | A bilayer mupirocin/bupivacaine-loaded wound dressing based on chitosan/poly (vinyl alcohol) nanofibrous mat: Preparation, characterization, and controlled drug release | |
| AU2018249552A1 (en) | Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety | |
| Pelegrino et al. | Chitosan-Based Nanomaterials for Skin Regeneration. | |
| Yue et al. | A bacteria-resistant and self-healing spray dressing based on lyotropic liquid crystals to treat infected post-operative wounds | |
| Radoor et al. | Alginate-based bionanocomposites in wound dressings | |
| IL299769A (en) | Eye supplement containing glucocorticoid | |
| IL295357A (en) | Preparations and methods for the treatment of eye diseases | |
| WO2019099630A1 (en) | Gel for treating periocular and/or orbital pathologies and conditions | |
| KR20160127672A (ko) | 생체적합성 천연고분자 및 dna 단편 혼합물을 함유하는 유착방지제 및 이의 제조 방법 | |
| Saliy et al. | Development strategy of novel drug formulations for the delivery of doxycycline in the treatment of wounds of various etiologies | |
| KR20180066104A (ko) | 무균 수성 안과용 액제의 치료적 용도 | |
| Sharma et al. | Ocular Bioadhesive Drug Delivery Systems and Their Applications | |
| WO2017162822A1 (en) | Compositions for mucosal adhesion and uses thereof |